 |
|
Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
Jung Goo Lee, Sae Woom Lee, Bong Ju Lee, Sung Woo Park, Gyung Mee Kim, Young Hoon Kim
Psychiatry Investig. 2012;9(2):166-173. Published online 2012 May 22 DOI: https://doi.org/10.4306/pi.2012.9.2.166
|
|
Comprehensive evaluation of 45 augmentation drugs for schizophrenia: a network meta-analysis
Damien Etchecopar-Etchart, Dong Keon Yon, Piotr Wojciechowski, Samuel Aballea, Mondher Toumi, Laurent Boyer, Guillaume Fond
eClinicalMedicine.2024; 69: 102473. CrossRef Augmentation Therapies as Treatments for Coexisting Somatic Problems in Schizophrenia—A Systematic Review
Wiktor Dróżdż, Michał Wiciński, Anna Maria Szota, Monika Szambelan, Izabela Radajewska, Igor Popławski, Paweł Wojciechowski
Journal of Clinical Medicine.2023; 12(12): 4012. CrossRef Unveiling the Enigma: Exploring Risk Factors and Mechanisms for Psychotic Symptoms in Alzheimer’s Disease through Electronic Medical Records with Deep Learning Models
Peihao Fan, Oshin Miranda, Xiguang Qi, Julia Kofler, Robert A. Sweet, Lirong Wang
Pharmaceuticals.2023; 16(7): 911. CrossRef Accessory Effect of Memantine on Negative Symptoms of Schizophrenia Patients: A Controlled Study
乘洋 刘
Advances in Clinical Medicine.2023; 13(10): 16326. CrossRef Memantine: procognitive and antinegative effects in mental illness (a literature review)
D. V. Romanov, P. G. Yuzbashyan
Neurology, Neuropsychiatry, Psychosomatics.2020; 12(3): 117. CrossRef Glutamate modulators for treatment of schizophrenia
Naista Zhand, David G. Attwood, Philip D. Harvey
Personalized Medicine in Psychiatry.2019; 15-16: 1. CrossRef Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials
Wei Zheng, Xiao-Min Zhu, Qing-E Zhang, Dong-Bin Cai, Xin-Hu Yang, Yan-Ling Zhou, Gabor S. Ungvari, Chee H. Ng, Shu-Hua He, Xiao-Jiang Peng, Yu-Ping Ning, Yu-Tao Xiang
Schizophrenia Research.2019; 209: 12. CrossRef Adjunctive Memantine Treatment of Schizophrenia
Fatemeh Hassanpour, Mehran Zarghami, Sussan Mouodi, Mahmood Moosazadeh, Fatemeh Barzegar, Maedeh Bagheri, Narjes Hendouei
Journal of Clinical Psychopharmacology.2019; 39(6): 634. CrossRef Clozapine augmentation strategies
James L. Roerig
Mental Health Clinician.2019; 9(6): 336. CrossRef Ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease
Jeffrey Fessel
Alzheimer's & Dementia: Translational Research & Clinical Interventions.2019; 5(1): 899. CrossRef Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials
W. Zheng, X-H. Li, X-H. Yang, D-B. Cai, G. S. Ungvari, C. H. Ng, S-B. Wang, Y-Y. Wang, Y-P. Ning, Y-T. Xiang
Psychological Medicine.2018; 48(1): 72. CrossRef L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial
Alireza Ghajar, Mohammad-Reza Khoaie-Ardakani, Zahara Shahmoradi, Amir-Reza Alavi, Mohsen Afarideh, Mohammad-Reza Shalbafan, Maryam Ghazizadeh-Hashemi, Shahin Akhondzadeh
Psychiatry Research.2018; 262: 94. CrossRef Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
Wen-Yu Hsu, Hsien-Yuan Lane, Chieh-Hsin Lin
Frontiers in Psychiatry.2018;[Epub] CrossRef Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis
Igne Sinkeviciute, Marieke Begemann, Merel Prikken, Bob Oranje, Erik Johnsen, Wan U. Lei, Kenneth Hugdahl, Rune A. Kroken, Carina Rau, Jolien D. Jacobs, Silvia Mattaroccia, Iris E. Sommer
npj Schizophrenia.2018;[Epub] CrossRef Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia
Maju Mathew Koola
Complex Psychiatry.2018; 4(3): 134. CrossRef Efficacy of Memantine in Schizophrenic Patients: A Systematic Review
Giuseppe Di Iorio, Gaia Baroni, Marco Lorusso, Chiara Montemitro, Maria Chiara Spano, Massimo di Giannantonio
Journal of Amino Acids.2017; 2017: 1. CrossRef Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies
Colm M P O'Tuathaigh, Paula M Moran, Xuechu C Zhen, John L Waddington
British Journal of Pharmacology.2017; 174(19): 3173. CrossRef Effects of memantine added to risperidone on the symptoms of schizophrenia: A randomized double-blind, placebo-controlled clinical trial
Robabeh Mazinani, Somayeh Nejati, Mohammadreza Khodaei
Psychiatry Research.2017; 247: 291. CrossRef Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis
Taro Kishi, Yuki Matsuda, Nakao Iwata
Psychopharmacology.2017; 234(14): 2113. CrossRef Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries
Ricardo P. Garay, Leslie Citrome, Ludovic Samalin, Chen-Chung Liu, Morten S. Thomsen, Christoph U. Correll, Ahcène Hameg, Pierre-Michel Llorca
Expert Opinion on Pharmacotherapy.2016; 17(7): 921. CrossRef Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study
S. R. T. Veerman, P. F. J. Schulte, J. D. Smith, L. de Haan
Psychological Medicine.2016; 46(9): 1909. CrossRef Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy
Savita G. Bhakta, Hsun-Hua Chou, Brinda Rana, Jo A. Talledo, Bryan Balvaneda, Laura Gaddis, Gregory A. Light, Neal R. Swerdlow
Psychopharmacology.2016; 233(12): 2399. CrossRef Effect of Memantine on Cognitive Performance in Patients Under Electroconvulsive Therapy
Narges Shams Alizadeh, Azad Maroufi, Mehnoosh Jamshidi, Kambiz Hassanzadeh, Fardin Gharibi, Ebrahim Ghaderi
Clinical Neuropharmacology.2015; 38(6): 236. CrossRef Cognitive enhancing agents in schizophrenia and bipolar disorder
Annabel Vreeker, Annet H. van Bergen, René S. Kahn
European Neuropsychopharmacology.2015; 25(7): 969. CrossRef Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia
Maju Mathew Koola, Robert W. Buchanan, Anilkumar Pillai, Katherine J. Aitchison, Daniel R. Weinberger, Scott T. Aaronson, Faith B. Dickerson
Schizophrenia Research.2014; 157(1-3): 84. CrossRef Psychopharmacological Treatment of Neurocognitive Deficits in People with Schizophrenia: A Review of Old and New Targets
Anthony O. Ahmed, Ishrat A. Bhat
CNS Drugs.2014; 28(4): 301. CrossRef Are NMDA receptor antagonists beneficial in the treatment of schizophrenia?
Seong S. Shim, Rashid Nadeem
Journal of Psychiatric Research.2014; 51: 19. CrossRef A Review of Pharmacological Strategy for Cognitive Deficits in Schizophrenia
Dong-Wook Jeon, Do-Un Jung, Bo-Geum Kong, Je-Wook Kang, Jung-Joon Moon, Joo-Cheol Shim
Korean Journal of Schizophrenia Research.2014; 17(2): 55. CrossRef Tackling Negative Symptoms of Schizophrenia with Memantine
Antonios Paraschakis
Case Reports in Psychiatry.2014; 2014: 1. CrossRef Critics on "Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study"
Chi-Un Pae
Psychiatry Investigation.2013; 10(1): 98. CrossRef NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials
Taro Kishi, Nakao Iwata
Journal of Psychiatric Research.2013; 47(9): 1143. CrossRef Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials
Yuki Matsuda, Taro Kishi, Nakao Iwata
Journal of Psychiatric Research.2013; 47(12): 2018. CrossRef Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
Bong Ju Lee, Seung Ju Lee, Min Kyung Kim, Jung Goo Lee, Sung Woo Park, Gyung Mee Kim, Young Hoon Kim
Clinical Psychopharmacology and Neuroscience.2013; 11(2): 60. CrossRef
|